US Patent 11458167 Bispecific CAR T-cells for solid tumor targeting
Patent 11458167 was granted and assigned to Seattle Children's on October, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11458167 Bispecific CAR T-cells for solid tumor targeting
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
